Foster Dykema Cabot & Co’s Amgen AMGN Stock Holding History

Foster Dykema Cabot & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$165K	Buy	614 +50	+9%	+$12.5K	0.02%	103
2023 Q2	$125K	Buy	564 +144	+34%	+$33.4K	0.01%	127
2023 Q1	$102K	Buy	+420	New	+$103K	0.01%	122
2017 Q1	–	Sell	-25,708	Closed	-$3.76M	–	107
2016 Q4	$3.76M	Buy	25,708 +640	+3%	+$96.3K	0.71%	26
2016 Q3	$4.18M	Sell	25,068 -70	-0.3%	-$11.8K	0.91%	26
2016 Q2	$3.83M	Sell	25,138 -900	-3%	-$140K	0.89%	28
2016 Q1	$3.9M	Buy	26,038 +32	+0.1%	+$4.75K	0.95%	26
2015 Q4	$4.22M	Sell	26,006 -1,430	-5%	-$225K	1.06%	23
2015 Q3	$3.79M	Buy	27,436 +240	+0.9%	+$37.8K	0.97%	24
2015 Q2	$4.17M	Buy	+27,196	New	+$4.36M	1.08%	25

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Foster Dykema Cabot & Co's AMGN Position: Q3 2023 in Review

Foster Dykema Cabot & Co increased its Amgen (AMGN) stake by 8.9% in Q3 2023, buying an estimated $12.5K and bringing the position to 614 shares worth $165K. The position accounts for 0.02% of the portfolio, ranked #103.

Foster Dykema Cabot & Co first reported a position in AMGN in Q2 2015 and has held it in 10 quarters since. The position peaked at $4.22M in Q4 2015. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

Foster Dykema Cabot & Co held 614 shares of Amgen worth $165K as of Q3 2023.
Foster Dykema Cabot & Co bought 50 Amgen shares in Q3 2023, an estimated $12.5K.
Amgen made up 0.02% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #103 holding.
Foster Dykema Cabot & Co first reported a position in Amgen in Q2 2015 and has held it in 10 quarters since.
Foster Dykema Cabot & Co's Amgen position peaked at $4.22M in Q4 2015.
2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.